KLHL17 activators belong to a class of chemical compounds that target and modulate the activity of the KLHL17 protein, which is a member of the Kelch-like family characterized by a series of repeats that form a kelch motif. KLHL17, also known as kelch-like protein 17, is implicated in a variety of cellular processes due to its role in protein-protein interactions. These activators are designed to enhance the function of KLHL17, either by increasing its stability, promoting its interaction with other proteins, or facilitating its localization to specific cellular compartments where it exerts its action. The molecular intricacies of KLHL17 activation are complex, as the process may involve conformational changes in the protein structure that enhance its affinity for partner proteins or substrates, or perhaps the prevention of degradation pathways that would otherwise decrease KLHL17 levels.
The development and characterization of KLHL17 activators require a detailed understanding of the protein's structure and the molecular pathways it is involved in. The activators typically work by binding to the KLHL17 protein at specific sites that are critical for its function. These sites could be located in the kelch domain or other functional domains of the protein, which play a role in its ability to interact with other proteins and execute its functions. By binding to these sites, KLHL17 activators can induce conformational changes that either expose interaction sites or stabilize the protein in a configuration that is more conducive to function.
VOIR ÉGALEMENT...
| Nom du produit | CAS # | Ref. Catalogue | Quantité | Prix HT | CITATIONS | Classement |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Un inhibiteur de GSK-3β qui peut stabiliser les protéines en empêchant leur ubiquitination et leur dégradation, ce qui peut indirectement augmenter les niveaux de KLHL17. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Un inhibiteur de l'ADN méthyltransférase qui pourrait conduire à la déméthylation et à la transcription ultérieure des gènes, affectant potentiellement l'expression de KLHL17. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Inhibiteur de l'histone-désacétylase qui peut augmenter l'expression des gènes en modifiant la structure de la chromatine, ce qui peut conduire à une synthèse accrue de KLHL17. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $70.00 $198.00 | 18 | |
Un autre inhibiteur de GSK-3β qui peut augmenter la stabilité de la protéine et peut augmenter les niveaux ou l'activité de KLHL17. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Inhibiteur du protéasome utilisé pour bloquer la dégradation des protéines ubiquitinées, ce qui peut stabiliser KLHL17. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Activateur de l'adénylate cyclase qui augmente les niveaux d'AMPc intracellulaire, ce qui peut entraîner une modification de l'expression génétique et une augmentation des niveaux de KLHL17. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Inhibiteur de l'histone désacétylase qui peut augmenter l'acétylation des histones, conduisant à une structure chromatinienne plus détendue et à une expression potentiellement plus élevée de KLHL17. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Un inhibiteur de ROCK qui peut influencer l'organisation du cytosquelette et pourrait affecter les processus cellulaires impliquant KLHL17. | ||||||